Tumor lysis syndrome (TLS) is a potentially life-threatening metabolic disorder characterized by an elevated uric acid level, elevated serum potassium and phosphorus levels, and a decreased calcium level.
Jeanne Held-warmkessel, MSN
Advertisement
Articles by Jeanne Held-warmkessel, MSN
Advertisement
Latest Updated Articles
A Patient With Tumor Lysis SyndromePublished: August 27th 2012 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
Frontline Alectinib Upholds OS Benefit in Advanced ALK+ NSCLC
2
Episode 16: Anticipated ESMO 2025 Data That May Change GU Oncology
3
Perioperative Durvalumab/NAT Chemo Does Not Improve HRQOL in MIBC
4
Osimertinib/Chemo Yields OS Improvement Across Subgroups of EGFR+ NSCLC
5
